Loading…

Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer

Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. It is more common in developed countries and has become one of the main causes of death in some countries and regions. Currently, pancreatic cancer generally has a poor prognosis, partly due...

Full description

Saved in:
Bibliographic Details
Published in:Glycoconjugate journal 2021-04, Vol.38 (2), p.213-231
Main Authors: Lu, Haoran, Xiao, Kaijie, Tian, Zhixin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843
cites cdi_FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843
container_end_page 231
container_issue 2
container_start_page 213
container_title Glycoconjugate journal
container_volume 38
creator Lu, Haoran
Xiao, Kaijie
Tian, Zhixin
description Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. It is more common in developed countries and has become one of the main causes of death in some countries and regions. Currently, pancreatic cancer generally has a poor prognosis, partly due to the lack of symptoms in the early stages of pancreatic cancer. Therefore, most cases are diagnosed at advanced stage. With the continuous in-depth research of glycoproteomics in precision medical diagnosis, there have been some reports on quantitative analysis of cancer-related cells, plasma or tissues to find specific biomarkers for targeted therapy. This research is based on the developed complete N-linked glycopeptide database search engine GPSeeker, combined with liquid-mass spectrometry and stable diethyl isotope labeling, providing a benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers. With spectrum-level FDR ≤1%, 20,038 intact N-Glycopeptides corresponding to 4518 peptide backbones, 228 N-glycan monosaccharide compositions 1026 N-glycan putative structures, 4460 N-glycosites and 3437 intact N-glycoproteins were identified. With the criteria of ≥1.5-fold change and p value
doi_str_mv 10.1007/s10719-021-09994-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2511242488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2511242488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843</originalsourceid><addsrcrecordid>eNp9kc1uFDEQhC1ERDaBF-CALHHhYvDfjG1uEEFAipJLOFteT09wmB1v_BNp34cHxcMEEBw49aG_qupWIfSc0deMUvUmM6qYIZQzQo0xkuhHaMM6JYg0un-MNpRrTijV9Bid5HxLm0hy_QQdC6FFJ6TaoO_vYfZfdy59w3HEORQg2M0DziVVX2oCkvfgwxg8vqtuLqG4Eu4Bl5BzBXxJbqaDj_sUC8Rd8BmPMeEhZB_vIR0Wz31bNZ2b_oLDjJdQSPktdti7DC2yDqvCzT5By_FtMXtIT9HR6KYMzx7mKfry8cP12SdycXX--ezdBfFCdYW4bmsUF4NzgxmcVuOWSerVSAV1svdC91KrwffOmC0Hr5niTFGlJDPKaC3FKXq1-rYT7yrkYnftE5gmN0Os2fKOMS651LqhL_9Bb2NNc7tuoYTktOtZo_hK-RRzTjDafQrt74Nl1C4d2rVD2zq0Pzu0i_WLB-u63cHwW_KrtAaIFchtNd9A-pP9H9sfqrip7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2513420561</pqid></control><display><type>article</type><title>Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer</title><source>Springer Nature</source><creator>Lu, Haoran ; Xiao, Kaijie ; Tian, Zhixin</creator><creatorcontrib>Lu, Haoran ; Xiao, Kaijie ; Tian, Zhixin</creatorcontrib><description>Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. It is more common in developed countries and has become one of the main causes of death in some countries and regions. Currently, pancreatic cancer generally has a poor prognosis, partly due to the lack of symptoms in the early stages of pancreatic cancer. Therefore, most cases are diagnosed at advanced stage. With the continuous in-depth research of glycoproteomics in precision medical diagnosis, there have been some reports on quantitative analysis of cancer-related cells, plasma or tissues to find specific biomarkers for targeted therapy. This research is based on the developed complete N-linked glycopeptide database search engine GPSeeker, combined with liquid-mass spectrometry and stable diethyl isotope labeling, providing a benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers. With spectrum-level FDR ≤1%, 20,038 intact N-Glycopeptides corresponding to 4518 peptide backbones, 228 N-glycan monosaccharide compositions 1026 N-glycan putative structures, 4460 N-glycosites and 3437 intact N-glycoproteins were identified. With the criteria of ≥1.5-fold change and p value&lt;0.05, 52 differentially expressed intact N-glycopeptides (DEGPs) were found in pancreatic cancer tussues relative to control, where 38 up-regulated and 14 down-regulated, respectively.</description><identifier>ISSN: 0282-0080</identifier><identifier>EISSN: 1573-4986</identifier><identifier>DOI: 10.1007/s10719-021-09994-8</identifier><identifier>PMID: 33835347</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Antibiotics ; Benchmarking ; Biochemistry ; Biomarkers, Tumor - metabolism ; Biomedical and Life Sciences ; Databases, Protein ; Gastrointestinal tract ; Glycopeptides ; Glycoproteins ; Glycoproteins - analysis ; Glycoproteins - chemistry ; Glycoproteins - metabolism ; Humans ; Isotope Labeling ; Life Sciences ; Mass Spectrometry and the Analysis of Glycoconjugates ; Mass spectroscopy ; Monosaccharides ; Original Article ; Pancreatic cancer ; Pancreatic Neoplasms - metabolism ; Pathology ; Proteomics - methods ; Search Engine ; Tandem Mass Spectrometry - methods</subject><ispartof>Glycoconjugate journal, 2021-04, Vol.38 (2), p.213-231</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843</citedby><cites>FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843</cites><orcidid>0000-0002-2651-8524 ; 0000-0002-2877-8282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33835347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Haoran</creatorcontrib><creatorcontrib>Xiao, Kaijie</creatorcontrib><creatorcontrib>Tian, Zhixin</creatorcontrib><title>Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer</title><title>Glycoconjugate journal</title><addtitle>Glycoconj J</addtitle><addtitle>Glycoconj J</addtitle><description>Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. It is more common in developed countries and has become one of the main causes of death in some countries and regions. Currently, pancreatic cancer generally has a poor prognosis, partly due to the lack of symptoms in the early stages of pancreatic cancer. Therefore, most cases are diagnosed at advanced stage. With the continuous in-depth research of glycoproteomics in precision medical diagnosis, there have been some reports on quantitative analysis of cancer-related cells, plasma or tissues to find specific biomarkers for targeted therapy. This research is based on the developed complete N-linked glycopeptide database search engine GPSeeker, combined with liquid-mass spectrometry and stable diethyl isotope labeling, providing a benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers. With spectrum-level FDR ≤1%, 20,038 intact N-Glycopeptides corresponding to 4518 peptide backbones, 228 N-glycan monosaccharide compositions 1026 N-glycan putative structures, 4460 N-glycosites and 3437 intact N-glycoproteins were identified. With the criteria of ≥1.5-fold change and p value&lt;0.05, 52 differentially expressed intact N-glycopeptides (DEGPs) were found in pancreatic cancer tussues relative to control, where 38 up-regulated and 14 down-regulated, respectively.</description><subject>Antibiotics</subject><subject>Benchmarking</subject><subject>Biochemistry</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Biomedical and Life Sciences</subject><subject>Databases, Protein</subject><subject>Gastrointestinal tract</subject><subject>Glycopeptides</subject><subject>Glycoproteins</subject><subject>Glycoproteins - analysis</subject><subject>Glycoproteins - chemistry</subject><subject>Glycoproteins - metabolism</subject><subject>Humans</subject><subject>Isotope Labeling</subject><subject>Life Sciences</subject><subject>Mass Spectrometry and the Analysis of Glycoconjugates</subject><subject>Mass spectroscopy</subject><subject>Monosaccharides</subject><subject>Original Article</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pathology</subject><subject>Proteomics - methods</subject><subject>Search Engine</subject><subject>Tandem Mass Spectrometry - methods</subject><issn>0282-0080</issn><issn>1573-4986</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1uFDEQhC1ERDaBF-CALHHhYvDfjG1uEEFAipJLOFteT09wmB1v_BNp34cHxcMEEBw49aG_qupWIfSc0deMUvUmM6qYIZQzQo0xkuhHaMM6JYg0un-MNpRrTijV9Bid5HxLm0hy_QQdC6FFJ6TaoO_vYfZfdy59w3HEORQg2M0DziVVX2oCkvfgwxg8vqtuLqG4Eu4Bl5BzBXxJbqaDj_sUC8Rd8BmPMeEhZB_vIR0Wz31bNZ2b_oLDjJdQSPktdti7DC2yDqvCzT5By_FtMXtIT9HR6KYMzx7mKfry8cP12SdycXX--ezdBfFCdYW4bmsUF4NzgxmcVuOWSerVSAV1svdC91KrwffOmC0Hr5niTFGlJDPKaC3FKXq1-rYT7yrkYnftE5gmN0Os2fKOMS651LqhL_9Bb2NNc7tuoYTktOtZo_hK-RRzTjDafQrt74Nl1C4d2rVD2zq0Pzu0i_WLB-u63cHwW_KrtAaIFchtNd9A-pP9H9sfqrip7w</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Lu, Haoran</creator><creator>Xiao, Kaijie</creator><creator>Tian, Zhixin</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2651-8524</orcidid><orcidid>https://orcid.org/0000-0002-2877-8282</orcidid></search><sort><creationdate>20210401</creationdate><title>Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer</title><author>Lu, Haoran ; Xiao, Kaijie ; Tian, Zhixin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Benchmarking</topic><topic>Biochemistry</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Biomedical and Life Sciences</topic><topic>Databases, Protein</topic><topic>Gastrointestinal tract</topic><topic>Glycopeptides</topic><topic>Glycoproteins</topic><topic>Glycoproteins - analysis</topic><topic>Glycoproteins - chemistry</topic><topic>Glycoproteins - metabolism</topic><topic>Humans</topic><topic>Isotope Labeling</topic><topic>Life Sciences</topic><topic>Mass Spectrometry and the Analysis of Glycoconjugates</topic><topic>Mass spectroscopy</topic><topic>Monosaccharides</topic><topic>Original Article</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pathology</topic><topic>Proteomics - methods</topic><topic>Search Engine</topic><topic>Tandem Mass Spectrometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Haoran</creatorcontrib><creatorcontrib>Xiao, Kaijie</creatorcontrib><creatorcontrib>Tian, Zhixin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Journals (ProQuest Database)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Glycoconjugate journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Haoran</au><au>Xiao, Kaijie</au><au>Tian, Zhixin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer</atitle><jtitle>Glycoconjugate journal</jtitle><stitle>Glycoconj J</stitle><addtitle>Glycoconj J</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>38</volume><issue>2</issue><spage>213</spage><epage>231</epage><pages>213-231</pages><issn>0282-0080</issn><eissn>1573-4986</eissn><abstract>Pancreatic cancer is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. It is more common in developed countries and has become one of the main causes of death in some countries and regions. Currently, pancreatic cancer generally has a poor prognosis, partly due to the lack of symptoms in the early stages of pancreatic cancer. Therefore, most cases are diagnosed at advanced stage. With the continuous in-depth research of glycoproteomics in precision medical diagnosis, there have been some reports on quantitative analysis of cancer-related cells, plasma or tissues to find specific biomarkers for targeted therapy. This research is based on the developed complete N-linked glycopeptide database search engine GPSeeker, combined with liquid-mass spectrometry and stable diethyl isotope labeling, providing a benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers. With spectrum-level FDR ≤1%, 20,038 intact N-Glycopeptides corresponding to 4518 peptide backbones, 228 N-glycan monosaccharide compositions 1026 N-glycan putative structures, 4460 N-glycosites and 3437 intact N-glycoproteins were identified. With the criteria of ≥1.5-fold change and p value&lt;0.05, 52 differentially expressed intact N-glycopeptides (DEGPs) were found in pancreatic cancer tussues relative to control, where 38 up-regulated and 14 down-regulated, respectively.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33835347</pmid><doi>10.1007/s10719-021-09994-8</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-2651-8524</orcidid><orcidid>https://orcid.org/0000-0002-2877-8282</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0282-0080
ispartof Glycoconjugate journal, 2021-04, Vol.38 (2), p.213-231
issn 0282-0080
1573-4986
language eng
recordid cdi_proquest_miscellaneous_2511242488
source Springer Nature
subjects Antibiotics
Benchmarking
Biochemistry
Biomarkers, Tumor - metabolism
Biomedical and Life Sciences
Databases, Protein
Gastrointestinal tract
Glycopeptides
Glycoproteins
Glycoproteins - analysis
Glycoproteins - chemistry
Glycoproteins - metabolism
Humans
Isotope Labeling
Life Sciences
Mass Spectrometry and the Analysis of Glycoconjugates
Mass spectroscopy
Monosaccharides
Original Article
Pancreatic cancer
Pancreatic Neoplasms - metabolism
Pathology
Proteomics - methods
Search Engine
Tandem Mass Spectrometry - methods
title Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A42%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benchmark%20of%20site-%20and%20structure-specific%20quantitative%20tissue%20N-glycoproteomics%20for%20discovery%20of%20potential%20N-glycoprotein%20markers:%20a%20case%20study%20of%20pancreatic%20cancer&rft.jtitle=Glycoconjugate%20journal&rft.au=Lu,%20Haoran&rft.date=2021-04-01&rft.volume=38&rft.issue=2&rft.spage=213&rft.epage=231&rft.pages=213-231&rft.issn=0282-0080&rft.eissn=1573-4986&rft_id=info:doi/10.1007/s10719-021-09994-8&rft_dat=%3Cproquest_cross%3E2511242488%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-a5b9723daad9da87fb140c7f030a46c386487dc6a99b2ec817217077419798843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2513420561&rft_id=info:pmid/33835347&rfr_iscdi=true